Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-22-000081 General Corporate
Debt relative to revenue 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
88.79% · OPTIONAL · VALID
Capex intensity 27th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.35% · OPTIONAL · VALID
Operating cash generation 73th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
29.51% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
62.08% · CORE · VALID
Gross margin 35th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
77.79% · CORE · VALID
Operating margin 29th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-30.01% · CORE · VALID
R&D intensity 76th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
26.50% · OPTIONAL · VALID
SBC intensity 71th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
37.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 332.83%
Current 88.79%
Delta -244.04% Capex Intensity Decreased
Previous 9.62%
Current 6.35%
Delta -3.27% Cash Generation Increased
Previous 26.93%
Current 29.51%
Delta 2.58% Growth Decreased
Previous 62.59%
Current 62.08%
Delta -0.51% Margin Increased
Previous 77.68%
Current 77.79%
Delta 0.11% Profitability Increased
Previous -30.19%
Current -30.01%
Delta 0.18% R And D Intensity Decreased
Previous 26.70%
Current 26.50%
Delta -0.20% Sbc Intensity Increased
Previous 36.91%
Current 37.54%
Delta 0.63% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.